Institute of Medical Virology, University of Zürich, Zürich, Switzerland.
Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
PLoS Pathog. 2018 Jan 25;14(1):e1006825. doi: 10.1371/journal.ppat.1006825. eCollection 2018 Jan.
Broadly neutralizing antibodies (bnAbs) to HIV-1 can evolve after years of an iterative process of virus escape and antibody adaptation that HIV-1 vaccine design seeks to mimic. To enable this, properties that render HIV-1 envelopes (Env) capable of eliciting bnAb responses need to be defined. Here, we followed the evolution of the V2 apex directed bnAb lineage VRC26 in the HIV-1 subtype C superinfected donor CAP256 to investigate the phenotypic changes of the virus populations circulating before and during the early phases of bnAb induction. Longitudinal viruses that evolved from the VRC26-resistant primary infecting (PI) virus, the VRC26-sensitive superinfecting (SU) virus and ensuing PI-SU recombinants revealed substantial phenotypic changes in Env, with a switch in Env properties coinciding with early resistance to VRC26. Decreased sensitivity of SU-like viruses to VRC26 was linked with reduced infectivity, altered entry kinetics and lower sensitivity to neutralization after CD4 attachment. VRC26 maintained neutralization activity against cell-associated CAP256 virus, indicating that escape through the cell-cell transmission route is not a dominant escape pathway. Reduced fitness of the early escape variants and sustained sensitivity in cell-cell transmission are both features that limit virus replication, thereby impeding rapid escape. This supports a scenario where VRC26 allowed only partial viral escape for a prolonged period, possibly increasing the time window for bnAb maturation. Collectively, our data highlight the phenotypic plasticity of the HIV-1 Env in evading bnAb pressure and the need to consider phenotypic traits when selecting and designing Env immunogens. Combinations of Env variants with differential phenotypic patterns and bnAb sensitivity, as we describe here for CAP256, may maximize the potential for inducing bnAb responses by vaccination.
广泛中和抗体(bnAbs)能够针对 HIV-1 进化,这是一个经过多年病毒逃逸和抗体适应的迭代过程,HIV-1 疫苗设计试图模拟该过程。为了实现这一目标,需要确定使 HIV-1 包膜(Env)能够引发 bnAb 反应的特性。在这里,我们跟踪了 HIV-1 亚型 C 超级感染供体 CAP256 中 V2 顶点定向 bnAb 谱系 VRC26 的进化,以研究在 bnAb 诱导的早期阶段之前和期间循环的病毒群体的表型变化。从 VRC26 抗性原发性感染(PI)病毒、VRC26 敏感性超级感染(SU)病毒以及随后的 PI-SU 重组体中进化而来的纵向病毒显示出 Env 的显著表型变化,Env 特性的转变与早期对 VRC26 的抗性相吻合。SU 样病毒对 VRC26 的敏感性降低与感染性降低、进入动力学改变以及在 CD4 附着后对中和的敏感性降低有关。VRC26 对细胞相关 CAP256 病毒保持中和活性,表明通过细胞间传播途径的逃逸不是主要的逃逸途径。早期逃逸变体的适应性降低和细胞间传播中的持续敏感性都是限制病毒复制的特征,从而阻碍了快速逃逸。这支持了这样一种情况,即 VRC26 允许病毒在很长一段时间内仅部分逃逸,这可能增加了 bnAb 成熟的时间窗口。总的来说,我们的数据突出了 HIV-1 Env 在逃避 bnAb 压力方面的表型可塑性,并且在选择和设计 Env 免疫原时需要考虑表型特征。如我们在此处针对 CAP256 所描述的,具有不同表型模式和 bnAb 敏感性的 Env 变体的组合可能通过疫苗接种最大限度地提高诱导 bnAb 反应的潜力。